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Summary
Objectives: This study was performed to determine the incidence of herpes zoster and ser-
oprevalence of varicella-zoster virus (VZV) in young adults of South Korea, where VZV seropre-
valence remains relatively high.
Methods: In South Korea,military service is compulsory for all healthy youngmen and hence those
inmilitary servicemight provide a reflection of the general population. The computerized database
of the Armed Forces Medical Command was examined to identify the number of reported herpes
zoster cases. In order toevaluate VZV seroprevalence, serum sampleswere obtained fromrandomly
selected subjects among those who had been admitted to the Armed Forces Capital Hospital.
Results: A total of 705 cases of herpes zoster were reported between June 2004 and May 2005. The
annual incidence rate of herpes zoster was 141 (95% CI 131.0—151.8) per 100 000 population. A
total of 192 subjects were enrolled for the analysis of VZV seroprevalence. All subjects were male
and their median age was 21 (range 19—24) years. The overall anti-VZV IgG seropositivity
prevalence was 92.7% (178/192, 95% CI 88.0—95.7%).
Conclusion: We have described a population-based study of the epidemiology of VZV infections in
the military personnel of South Korea.
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Varicella-zoster virus (VZV) is a ubiquitous human herpesvirus
that causes varicella (chickenpox) and herpes zoster.1,2 After
primary infection the virus establishes latency in cells ofPublished by Elsevier Ltd. All rights reserved.
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approximately 15% of infected individuals over a lifetime.1,2
In temperate climates, chickenpox is predominantly a dis-
ease of childhood: seroprevalence studies show that 90% of
children have antibodies by the age of 15.3 In contrast, in
tropical areas, chickenpox occurs at older ages, around 20—
25 years, with the risk of developing more severe disease.4
Herpes zoster can occur any time after varicella, but the
incidence increases with age.
There are few population-based studies on the epidemiol-
ogy of herpes zoster, and contemporary estimates of herpes
zoster incidence are lacking. Furthermore, little data regard-
ing incidence and seroprevalence of VZV infections are avail-
able in South Korea, which is a typically high seroprevalence
country.We thus describe a population-based investigation of
the incidence of herpes zoster and seroprevalence of VZV in
young adults of South Korea, where VZV seroprevalence
remains relatively high.
Methods
In South Korea, military service is compulsory for all healthy
young men and hence those in military service might provide
a reflection of the general population, provided that the
sample population is corrected with respect to age and
gender distribution. The computerized database of the
Armed Forces Medical Command was examined to identify
the number of reported varicella and herpes zoster cases. In
the Korean Army, there is compulsory notification of indivi-
dual cases of communicable diseases, including VZV infec-
tion, to the Department of Preventive Medicine in the Armed
Forces Medical Command. Firstly we extracted data from the
Defense Medical Information System (DEMIS) and analyzed
data for varicella and herpes zoster cases that were sub-
mitted between June 2004 and May 2005. The annual inci-
dence rate was defined as cases per 100 000 people per year
among approximately 500 000 soldiers.
Secondly, we evaluated the seroprevalence of VZV infec-
tion. A total of 254 serum samples obtained from inpatients
for various laboratory tests between September 2005 and
February 2006 at a medical ward of the Armed Forces Capital
Hospital were available for analysis. This hospital provides
medical care to the troops that are stationed in the area
adjacent to Seoul, the capital of South Korea. Fifty-four
patients were excluded: those over 25 years of age, those
with chronic diseases such as cancer, diabetes mellitus, and
chronic renal diseases, those with varicella, those with
herpes zoster, immunocompromised cases including HIV
patients, and females. We, therefore, planned to obtain a
specific study group that included healthy young military
personnel. Of 200 subjects enrolled in the seroprevalence
study, eight subjects refused to participate. Thus, a total of
192 subjects were included in the analysis of VZV seropre-
valence. For the study population, information on their
history of varicella disease and then informed consent were
obtained. This study was approved by the institutional review
board of the Armed Forces Capital Hospital. Serum analyses
were performed at Seoul Clinical Laboratories (Seoul, Korea).
Anti-varicella virus IgG antibodies (anti-VZV IgG) were deter-
mined using Vircell ELISA kits (Vircell, Spain). The test was
performed in an automated format and cut-off values were
established according to the manufacturer’s instructions. Wecalculated the prevalence of VZV antibody as the number of
tests for which results were positive divided by the total
number of tests performed, with exact 95% confidence inter-
vals (95% CI) for proportions. Descriptive analysis including
95% CI was performed using the GraphPad QuickCalcs website
for statistics (http://www.graphpad.com/quickcalcs).
Results
A total of 197 varicella cases and 705 herpes zoster cases
were reported between June 2004 and May 2005. The annual
incidence rates of varicella and herpes zoster were 39.4 (95%
CI 30.1—45.1) and 141 (95% CI 131.0—151.8) per 100 000
people, respectively, based on the reported cases among
approximately 500 000 soldiers. No seasonal variation in
the monthly incidences was found.
A total of 192 patients were included for the analysis of
VZV seroprevalence. All patients were male and their median
age was 21 (range 19—24) years. The overall anti-VZV IgG
seropositivity prevalence was 92.7% (178/192, 95% CI 88.0—
95.7%). Of the 113 patients responding ‘no’ or ‘unknown’ to
inquiries about their history of chickenpox, 102 (90.3%) were
found to be VZV seropositive. Of the 79 patients responding
‘yes’ to inquiries about their history of chickenpox, 76
(96.2%) were found to be VZV seropositive.
Discussion
In South Korea, susceptibility to VZV infections in adult
populations is not well established. Also, data for the inci-
dence and seroepidemiology of VZV infections in young adults
have not previously been available. To the best of our knowl-
edge, this is the first study to report on the extent of VZV
infection in young soldiers in the army of South Korea, where
military service is compulsory for all healthy young men.
Over 90% of young adults in South Korea and in many other
countries have serologic evidence of VZV infections and are
at risk for herpes zoster. Table 1 shows recent data regarding
VZV seroprevalence in adolescents or young adults in other
countries.2,3,5—8 Increasing age is a key risk factor for the
development of herpes zoster. The other well-defined risk
factor for herpes zoster is altered cell-mediated immunity. In
this study population including young adults, the annual
incidence of herpes zoster was 141 per 100 000 people. It
is noted that herpes zoster occurred frequently in otherwise
healthy military personnel. However, even in previously
healthy infants and children, herpes zoster can occur at
any time after varicella or varicella vaccination.9
Approximately 7% of people were vulnerable to varicella
in our study population. Even though complications are rarely
seen, they could cause high morbidity and mortality in
military personnel. In 1995, varicella vaccination was intro-
duced into the infant immunization schedule in the USA.10 In
order to develop vaccination protocols and take appropriate
preventive healthcare measures against diseases in different
countries, it is very important to know the seroepidemiology
of any disease for that individual country. The present study
provides epidemiological data on VZV infections in Korean
military personnel based on the reported incidence data and
the determination of specific anti-VZV antibodies. However,
the population of this study was limited to young men and no
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Table 1 Recent studies on varicella-zoster virus seroprevalence in adolescents or young adults in other countries
Authors (year) [Ref.] Country Population Test Age (years) Gender N Rate (%)
Fairley and Miller (1996) [5] UK General ND 15 Both ND 95
Gil et al. (1998) [6] Spain General ELISA 14—17 Both 1191 93.7
Aebi et al. (2001) [7] Switzerland Pediatric patients IFA 12—16 Both 254 96.1
Alp et al. (2005) [3] Turkey General ELISA 16—30 Both 204 91.2
Wutzler et al. (2002) [2] Germany General ELISA 10—20 Both ND 94.2
Barnett et al. (2002) [8] USA Refugees ELISA 13—20 Both 217 81
This study (2006) South Korea Military personnel ELISA 19—24 Men 192 92.7
ND, no data; ELISA, enzyme-linked immunosorbent assay; IFA, indirect immunofluorescence assay.women were included. Epidemiological studies including the
general population are also warranted.
A reliable history of chickenpox is usually consistent with
immunity. Those without such a history are considered sus-
ceptible and can be tested to determine immune status or be
empirically vaccinated.11 Our evaluation of the serologic
status of young adults ranging in age from 19 to 24 years,
reflects an overall varicella immunity of 93%, and approxi-
mately 90% of adults who do not have a reliable history of
varicella are actually immune. Although a cost-effectiveness
analysis was not performed, our data suggest that serologic
testing before vaccination is likely to be cost-effective for
young adults, especially for those with negative varicella
history.
This study was based on routinely reported data and
recorded information. Although this type of study has the
advantage of allowing the study to be completed rapidly and
at a low cost, the quality of the data is sometimes not
optimal. Although the diagnosis of varicella or herpes zoster
is relatively simple in clinical practice without being con-
fused with other conditions causing vesicles, cases with
minor symptoms would not have been included in the data
if physicians had not seen them. However, clinical disease is
sufficiently severe that few cases would not come to the
attention of medical personnel in a modern military organi-
zation.
In conclusion, we have described a population-based study
of the epidemiology of VZV infections in young soldiers of
South Korea. The annual incidence rate of herpes zoster was
141 per 100 000 people, and the overall VZV seroprevalence
was approximately 93% in young adults of South Korea.
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